Jacques was Chief Scientific Officer at Arrakis Therapeutics, and Chief Scientific Officer at Tetraphase Pharmaceuticals. Jacques Dumas joined AiCuris in 2025.
Jacques Dumas is currently
Create your alert
to follow the career of Jacques Dumas.
Do you need to know more about Jacques Dumas? More results.
Report an error
Update the org chart details of Jacques Dumas.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.